Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Sedley -- patient - sdlittle

Jul 10, 2007 06:53AM

Jul 10, 2007 07:02AM

Jul 10, 2007 07:25AM

Jul 10, 2007 07:27AM

Jul 10, 2007 07:34AM

Jul 10, 2007 07:46AM
SGE

Jul 10, 2007 07:53AM

Jul 10, 2007 08:00AM

Jul 10, 2007 08:03AM

Jul 10, 2007 08:06AM

Jul 10, 2007 08:10AM

Jul 10, 2007 08:14AM

Jul 10, 2007 08:17AM

SGE,

You say 

"One would resonably assume, with what all PTSC had/has going for it, that the retail demand would be more than sufficient to overcome S&L's sell strategy."

and then say

 "What if PTSC pushed the PR button? Well, then would be viewed as a pump and dump scheme (and it would be, with S&L doing the dumping)."

 

How will there be a retail demand without PTSC pushing the "PR button"? Are you suggesting that retail investors should have purchased PTSC shares with confidence despite the clound of uncertainty that surrounded the trial with J3/ARM?

 


Jul 10, 2007 08:28AM

Jul 10, 2007 08:44AM

Jul 10, 2007 08:47AM

Jul 10, 2007 08:55AM

Jul 10, 2007 08:56AM

Jul 10, 2007 09:01AM
Share
New Message
Please login to post a reply